216 related articles for article (PubMed ID: 29230715)
21. The association between thyroid malignancy and chronic lymphocytic thyroiditis: should it alter the surgical approach?
Büyükaşık O; Hasdemir AO; Yalçın E; Celep B; Sengül S; Yandakçı K; Tunç G; Küçükpınar T; Alkoy S; Cöl C
Endokrynol Pol; 2011; 62(4):303-8. PubMed ID: 21879469
[TBL] [Abstract][Full Text] [Related]
22. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
[TBL] [Abstract][Full Text] [Related]
23. Pathologic spectrum of lymphocytic infiltration and recurrence of papillary thyroid carcinoma.
Kim HG; Kim EK; Han KH; Kim H; Kwak JY
Yonsei Med J; 2014 Jul; 55(4):879-85. PubMed ID: 24954314
[TBL] [Abstract][Full Text] [Related]
24. Epitope-Specific Antitumor Immunity Suppresses Tumor Spread in Papillary Thyroid Cancer.
Ehlers M; Kuebart A; Hautzel H; Enczmann J; Reis AC; Haase M; Allelein S; Dringenberg T; Schmid C; Schott M
J Clin Endocrinol Metab; 2017 Jul; 102(7):2154-2161. PubMed ID: 27860539
[TBL] [Abstract][Full Text] [Related]
25. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
[TBL] [Abstract][Full Text] [Related]
27. Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapy.
Carvalho MS; Rosario PW; Mourão GF; Calsolari MR
Endocrine; 2017 Mar; 55(3):954-958. PubMed ID: 27878772
[TBL] [Abstract][Full Text] [Related]
28. Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents.
Iliadou PK; Effraimidis G; Konstantinos M; Grigorios P; Mitsakis P; Patakiouta F; Pazaitou-Panayiotou K
Eur J Endocrinol; 2015 Dec; 173(6):827-33. PubMed ID: 26369577
[TBL] [Abstract][Full Text] [Related]
29. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
[TBL] [Abstract][Full Text] [Related]
30. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Liu Y; Yun X; Gao M; Yu Y; Li X
Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
[TBL] [Abstract][Full Text] [Related]
31. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.
Zhu Y; Zheng K; Zhang H; Chen L; Xue J; Ding M; Wu K; Wang Z; Kong L; Chen X
Tumour Biol; 2016 Jun; 37(6):8037-45. PubMed ID: 26711787
[TBL] [Abstract][Full Text] [Related]
32. The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer?
Del Rio P; Cataldo S; Sommaruga L; Concione L; Arcuri MF; Sianesi M
Minerva Endocrinol; 2008 Mar; 33(1):1-5. PubMed ID: 18277374
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Thyroiditis on the Yield of Central Compartment Lymph Nodes in Patients with Papillary Thyroid Cancer.
Lai V; Yen TW; Rose BT; Fareau GG; Misustin SM; Evans DB; Wang TS
Ann Surg Oncol; 2015 Dec; 22(13):4181-6. PubMed ID: 25851341
[TBL] [Abstract][Full Text] [Related]
34. Both gender and concurrent chronic lymphocytic thyroiditis may influence the nuclear texture of papillary thyroid carcinomas cells.
Cunha LL; Ferreira Rde C; de Matos PS; da Assumpção LV; Ward LS
Endocr Res; 2014; 39(3):126-9. PubMed ID: 24460065
[TBL] [Abstract][Full Text] [Related]
35. Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma.
Kurukahvecioglu O; Taneri F; Yüksel O; Aydin A; Tezel E; Onuk E
Adv Ther; 2007; 24(3):510-6. PubMed ID: 17660159
[TBL] [Abstract][Full Text] [Related]
36. Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
Marotta V; Sciammarella C; Chiofalo MG; Gambardella C; Bellevicine C; Grasso M; Conzo G; Docimo G; Botti G; Losito S; Troncone G; De Palma M; Giacomelli L; Pezzullo L; Colao A; Faggiano A
Endocr Relat Cancer; 2017 Sep; 24(9):485-493. PubMed ID: 28696209
[TBL] [Abstract][Full Text] [Related]
37. Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases.
Fiore E; Rago T; Scutari M; Ugolini C; Proietti A; Di Coscio G; Provenzale MA; Berti P; Grasso L; Mariotti S; Pinchera A; Vitti P
J Endocrinol Invest; 2009 Apr; 32(4):344-51. PubMed ID: 19636204
[TBL] [Abstract][Full Text] [Related]
38. Comparison of T stage, N stage, multifocality, and bilaterality in papillary thyroid carcinoma patients according to the presence of coexisting lymphocytic thyroiditis.
Park JY; Kim DW; Park HK; Ha TK; Jung SJ; Kim DH; Bae SK
Endocr Res; 2015; 40(3):151-5. PubMed ID: 25531396
[TBL] [Abstract][Full Text] [Related]
39. [Does chronic lymphocytic thyroiditis influence the staging of differentiated thyroid carcinoma?].
Nemetz MA; Thomazelli FC; Granero LC; Nemetz AB; Dos Santos MB
Braz J Otorhinolaryngol; 2011; 77(1):77-83. PubMed ID: 21340193
[TBL] [Abstract][Full Text] [Related]
40. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study.
Mazokopakis EE; Tzortzinis AA; Dalieraki-Ott EI; Tsartsalis AN; Syros PK; Karefilakis CM; Papadomanolaki MG; Starakis IK
Hormones (Athens); 2010; 9(4):312-7. PubMed ID: 21112862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
